4 citations
,
October 2021 in “Journal of The European Academy of Dermatology and Venereology” Low-dose oral minoxidil increases hair density and thickness in people with hair loss.
21 citations
,
March 2021 This study reviewed the literature on low-dose oral minoxidil as a primary treatment for various hair loss disorders, concluding that it is a successful and well-tolerated alternative to topical minoxidil for patients with poor adherence to other therapies.
June 2020 in “Acta medica Philippina” This research review suggests that topical adenosine could improve hair thickness and user satisfaction in adults with androgenetic alopecia, with minimal side effects reported, but concludes that further studies are necessary to confirm these findings.
June 2020 in “The Medical Journal of Cairo University” In this study, topical spironolactone was found to be more effective than topical finasteride for treating androgenetic alopecia in both males and females, with fewer side effects compared to oral finasteride.
5 citations
,
March 2020 in “Journal of Cosmetic Dermatology” This study found that using a high concentration of minoxidil with microneedling and carboxytherapy significantly increased hair growth in 9 adults with androgenetic alopecia, as measured by hair density and diameter improvements.
January 2020 in “Springer eBooks” 
1 citations
,
February 2019 in “PubMed” This source reports that topical minoxidil effectively treats hair loss in androgenetic alopecia, varying efficacy by ethnic groups, and when combined with other therapies, shows increased effectiveness for conditions like alopecia areata and congenital hair disorders.
December 2017 in “PubMed” This review examines low-level laser therapy as a potential treatment for androgenetic alopecia, presenting current clinical findings, proposed mechanisms, and rare side effects, but does not report new results.
This chapter reviews the causes, prevalence, and prognosis of androgenetic alopecia and discusses treatments like topical minoxidil and systemic finasteride to stop hair loss and potentially increase hair density.
January 2012 in “Journal of Practical Dermatology” This review discusses various treatments for androgenetic alopecia in both men and women and reports no new clinical results; the authors note the importance of understanding therapeutic mechanisms, dosages, and adverse reactions.
112 citations
,
October 2005 in “Mayo Clinic Proceedings” This article reviews the clinical, psychological, and management aspects of androgenetic alopecia in men, stating that it can be effectively managed by generalist clinicians with pharmacotherapy and surgical advancements.
29 citations
,
July 2003 in “PubMed” This article discusses the diagnosis and treatment of various alopecia types, including androgenetic alopecia and telogen effluvium, but reports no new clinical results.
229 citations
,
August 2002 in “Experimental Gerontology” This paper discusses key mechanisms of androgen metabolism in androgenetic alopecia and reports the effectiveness of treatments like oral finasteride and topical minoxidil, highlighting the limited success rate due to factors like follicular inflammation.
22 citations
,
March 2000 in “Clinics in Dermatology” This study developed a method using HPLC with UV-DAD and ESI-MS detection to identify prohibited substances like minoxidil and hormones in cosmetic products advertised online for hair loss and skin conditions.
June 1996 in “Archives of Dermatology” This article reviews a case of impressive hair regrowth in a man with androgenetic alopecia using a combination of topical minoxidil and tretinoin, but provides no clinical trial results; the authors call for informed consent before recommending this treatment.
3 citations
,
October 1988 in “Clinics in Dermatology” This study found that 3% topical minoxidil decreased hair shedding and promoted hair growth in women with androgenetic alopecia.
